310
Participants
Start Date
November 12, 2019
Primary Completion Date
June 16, 2022
Study Completion Date
June 16, 2022
NYX-2925
NYX-2925 administered orally
Placebo
Placebo administered orally
Aptinyx Clinical Site, New York
Aptinyx Clinical Site, New York
Aptinyx Clinical Site, Staten Island
Aptinyx Clinical Site, Brooklyn
Aptinyx Clinical Site, Williamsville
Aptinyx Clinical Site, Duncansville
Aptinyx Clinical Site, Danville
Aptinyx Clinical Site, Alpharetta
Aptinyx Clinical Site, Fernandina Beach
Aptinyx Clinical Site, Lady Lake
Aptinyx Clinical Site, Jacksonville
Aptinyx Clinical Site, Jacksonville
Aptinyx Clinical Site, Winter Park
Aptinyx Clinical Site, Orlando
Aptinyx Clinical Site, Palmetto Bay
Aptinyx Clinical Site, Miami
Aptinyx Clinical Site, Memphis
Aptinyx Clinical Site, Cincinnati
Aptinyx Clinical Site, Evansville
Aptinyx Clinical Site, West Des Moines
Aptinyx Clinical Site, Gurnee
Aptinyx Clinical Site, Skokie
Aptinyx Clinical Site, Flossmoor
Aptinyx Clinical Site, Chicago
Aptinyx Clinical Site, Hazelwood
Aptinyx Clinical Site, Prairie Village
Aptinyx Clinical Site, Newton
Aptinyx Clinical Site, Wichita
Aptinyx Clinical Site, Omaha
Aptinyx Clinical Site, Oklahoma City
Aptinyx Clinical Site, Houston
Aptinyx Clinical Site, Austin
Aptinyx Clinical Site, Phoenix
Aptinyx Clinical Site, Las Vegas
Aptinyx Clinical Site, Culver City
Aptinyx Clinical Site, Torrance
Aptinyx Clinical Site, Redlands
Aptinyx Clinical Site, Temecula
Aptinyx Clinical Site, Orange
Aptinyx Clinical Site, Fresno
Aptinyx Clinical Site, Bellevue
Aptinyx Clinical Site, Roslindale
Lead Sponsor
Collaborators (1)
Worldwide Clinical Trials
OTHER
Aptinyx
INDUSTRY